Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress

The Finnish company shared technical specifications for the ST500

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

Rick Lewis, MD, speaks about a non-pharmaceutical approach to treating glaucoma with laser technology

Phase 1 multicentre study data demonstrate early signs of efficacy

The ESCRS Moving Simulator initiative brings surgical training to nations in need

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

A case report demonstrates independent effect of GLP-1 receptor agonist

Akantior, an anti-amoebic polymer eye drop, is the first and only authorised medical product for the treatment of AK in the world, according to a news release.

The future of the tech-forward surgical suite

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain

European patients navigate new therapies and market change-ups